Avoro Capital Advisors’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-473,100	Closed	-$13.9M	–	44
2023 Q1	$13.9M	Sell	473,100 -156,900	-25%	-$4.6M	0.21%	34
2022 Q4	$23.3M	Sell	630,000 -20,000	-3%	-$739K	0.35%	32
2022 Q3	$18.3M	Buy	+650,000	New	+$18.3M	0.34%	33